You are here

News & Events

Research News
Prota Therapeutics, a newly established Australian company, is developing MCRI’s patented probiotic immunotherapy for treating food allergies. You can visit Prota Therapeutics’s website to learn more. Prota Therapeutics is commercialising a world first peanut allergy treatment using probiotics developed by Professor Mimi Tang at the MCRI.
Institute News
Three of Australia’s child health leaders have joined forces to tackle global child health – the Murdoch Children’s Research Institute, The Royal Children’s Hospital and the University of Melbourne have launched a new initiative, Melbourne Children’s Global Health.
Institute News
Genetic counselling is one of the rarest jobs in Australia – with only 230 employed nationwide. Genetic counsellors work in many areas of medicine, including paediatrics, prenatal, infertility, neurology, cancer and cardiology. Many counsellors work directly with patients, while others carry out research in public laboratories and for industry.
Institute News
Murdoch Children’s Research Institute (MCRI) has attracted $34.2 million funding in the latest National Health and Medical Research Council (NHMRC) Grant Application Round. The funding has been awarded to 41 grants across the institute, which is an overall success rate of more than 31 per cent – significantly higher than the national rate of 19.5 per cent.
Research News
New research led by the Murdoch Children's Research Institute (MCRI), has combined gene editing technology with stem cell kidney regeneration to correct a patient’s gene mutation. This is the first time a patient has had kidney regenerated from their stem cells in Australia.